Search for: "Endo Pharmaceutical" Results 81 - 100 of 254
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Nov 2016, 4:57 am by Amber Walsh
Other healthcare investments have included American Sterilizer, Endo Pharmaceuticals, Spectramed, Unilab and Oceana Therapeutics. [read post]
28 Sep 2016, 8:39 am by Dennis Crouch
Momenta Pharmaceuticals, Inc., et al., No. 15-1402 (scope of 271(e) safe harbor) Post Grant Admin: Ethicon Endo-Surgery, Inc. v. [read post]
28 Jun 2016, 6:41 am by Dennis Crouch
., No. 15-998 (follow-on to SCA) Safe Harbor: Amphastar Pharmaceuticals, Inc., et al. v. [read post]
3 Jun 2016, 6:40 am by Dennis Crouch
., No. 15-998 (follow-on to SCA) Safe Harbor: Amphastar Pharmaceuticals, Inc., et al. v. [read post]
18 May 2016, 9:56 pm by Patent Docs
Endo Pharmaceuticals Inc. v. [read post]
18 May 2016, 8:19 am by Dennis Crouch
., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
3 May 2016, 1:42 am by Dennis Crouch
., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
18 Apr 2016, 12:49 pm by Gene Quinn
The complaint also names Allergan plc, the parent company of Watson, and Endo International plc, the parent company of Endo Pharmaceuticals Inc. [read post]
18 Apr 2016, 9:58 am by Dennis Crouch
., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
12 Apr 2016, 10:29 am
On March 30th, the Federal Trade Commission filed a lawsuit against drug manufacturer Endo Pharmaceuticals, alleging that Endo is paying generic drug manufacturers in order to delay the release of lower cost generic versions of their drugs, Opana ER and Lidoderm.Generic drugs come to market when the patents on name brand drugs expire. [read post]
1 Apr 2016, 8:22 am by Dennis Crouch
., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
1 Apr 2016, 5:30 am by Gene Quinn
The FTC’s complaint alleges that Endo paid the first generic companies that filed for FDA approval – Impax Laboratories, Inc. and Watson Laboratories, Inc. [read post]
1 Apr 2016, 5:30 am by Gene Quinn
The post FTC charges Endo Pharmaceuticals with antitrust violations for pay for delay patent settlements appeared first on IPWatchdog.com | Patents & Patent Law. [read post]
17 Mar 2016, 2:45 am by Dennis Crouch
Ethicon Endo-Surgery, Inc., No. 15-115 Nautilus, Inc. v. [read post]
4 Mar 2016, 12:25 pm by Dennis Crouch
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
25 Feb 2016, 7:32 am by Allred & Allred
Qualitest is headquartered in Huntsville, and is owned by larger firm Endo Pharmaceuticals, which is based in Dublin, Ireland. [read post]